Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for inhibiting cellular expression of Ifn[beta], Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4

A technology of gbp-1 and cells, applied in the field of biomedicine

Inactive Publication Date: 2016-07-06
宁波美丽人生医药生物科技发展有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

; For example, specific inhibitors of cyclooxygenase 1 increase the replication of pseudorabies virus PFV (Ray et al. 2004). Mice given cyclooxygenase 1 knockout but not given cyclooxygenase 2 knockout are more resistant to influenza virus Invasion (Carey et al 2005) and cyclooxygenase 1 promoter hyperacetylation produces interferon repression in histone deacetylation-deficient macrophages (Chen et al 2012) Although multiple studies have shown that cyclooxygenase 1 regulates Inhibition of type 1 interferons, but regulation of cyclooxygenase 1 by host antiviral responses remains poorly studied

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for inhibiting cellular expression of Ifn[beta], Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4
  • Method for inhibiting cellular expression of Ifn[beta], Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4
  • Method for inhibiting cellular expression of Ifn[beta], Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] RXR expression regulates host susceptibility to vesicular stomatitis virus infection:

[0055] Our previous genetic studies have established a new type RXR expression is downregulated by an interferon regulatory factor 3-dependent but interferon-independent mechanism (Chow et al. 2006). To determine RXR expression levels by different types of viral infection, bone marrow-derived macrophages were infected with vesicular stomatitis virus. The results showed that the expression of RXR was down-regulated after infection with the above viruses ( like figure 1 shown in A). Repression of the RXR gene was not due to changes in the cell state after infection, as the L32 control gene was unchanged (data not shown). Administration of the RNA virus analogue polyI:C and the DNA virus analogue polydA:dT can activate intracellular virus and also significantly inhibit the expression of RXR in bone marrow macrophages. ( like figure 1 Shown in B) More importantly, it confirms...

Embodiment 2

[0059] RXR agonists and their antagonists modulate host defense functions in vesicular stomatitis virus-injected macrophages:

[0060] Ligand binding to RXR can activate its downstream pathway, and it is fully activated. In order to explore whether RXR ligand activation can affect virus infection, RAW264.7 cells were pretreated overnight with RXR-specific agonists Ig268 and AGN194204, and then infected with vesicular stomatitis virus. Through plaque test analysis, the experimental results were consistent with the experimental results of RXR overexpression, and the RXR in the ligand activation group was given two stimulants, which significantly enhanced the level of vesicular stomatitis virus infection. ( like Figure 7 Shown in A) Similarly, administration of 9-cis retinoic acid (RXR new type Ligand) treatment can also increase the susceptibility of RAW264.7 cell line to vesicular stomatitis virus infection in a dose-dependent manner (retinoic acid dose range 16nM-20nM) (...

Embodiment 3

[0062] Ligand activation of RXR inhibits the expression of multiple antiviral genes:

[0063] In order to study how RXR weakens the host immune response and facilitates virus infection, the inventors of the present invention performed gene chip detection on the RXR agonist pretreatment group and macrophage PolyI:C transfection group. The results show that 9 cis retinoic acid can inhibit a variety of Poly1:C-induced genes, including type 1 interferon genes (such as IFN1, IFN2, IFN4, IFN5) Isg15, Ifit3 and Gbp3 ( like image 3 A) Considering type 1 interferon and its downstream interferon-stimulated gene I S Gs play an important role in the host's immune response in antiviral infection, and the RXR-mediated suppression of these antiviral genes may be caused by the host's susceptibility to viral infection. In order to verify the genetic data and prove the hypothesis that RXR is beneficial to virus infection by inhibiting antiviral genes, the inventors pretreated RAW264.7 cells...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for inhibiting cellular expression of Ifn[beta], Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4. The invention relates to the field of biological medicine, and in particular relates to a method for inhibiting the cellular expression of antiviral gene cells and the method is screened by measuring the expression quantities of Ifn[beta], Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4 and by constructing a vesicular stomatitis virus susceptible cell model caused by overexpression of RXRs (retinoid X receptors). The invention provides a constructing method of the vesicular stomatitis virus susceptible cell model caused by the overexpression of the RXRs, and applications of the RXRs in screening the method for inhibiting the cellular expression of the Ifn[beta], Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4, and finds that a COX sensing pathway inhibits antiviral genes in a host immune defense system through an RXR-dependent manner, and therefore, the practical application value of the RXRs in screening the method for inhibiting the cellular expression of the Ifn[beta], Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4 is further confirmed.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a method for inhibiting the expression of Ifnβ, Isg15, Gbp-1, Oas2, Irf7, Isg20 and Ifn4 cells. Background technique [0002] Immune activation during viral infection leads to downregulation of retinol X receptors, hereafter referred to as (RXR), RXR belongs to the nuclear receptors, which are essential in the metabolism of cells and the whole body. However, the role of RXR in host defense against viral infection remains unknown. Nuclear receptors (NRs) represent a large family of transcription factors involved in a broad spectrum of biological events, such as development, reproduction, and metabolism. (Robinson-Rechavi et al. 2003) Many members of the NR superfamily have emerged as key regulators of inflammation and immune responses (Daynes and Jones, 2002; Joseph et al. 2003; Ogawa et al. 2005), which enable macrophages and dendritic cells to sense its lipid environment and shapes ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/09
Inventor 田晓丽
Owner 宁波美丽人生医药生物科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com